Nifty
Sensex
:
:
14371.90
48878.54
-218.45 (-1.50%)
-746.22 (-1.50%)

Pharmaceuticals & Drugs - Veterinary

Rating :
52/99  (View)

BSE: 524669 | NSE: HESTERBIO

1655.15
-29.45 (-1.75%)
22-Jan-2021 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1675.00
  •  1707.80
  •  1651.00
  •  1684.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6620
  •  109.57
  •  1900.00
  •  864.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,409.50
  • 52.82
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,506.65
  • 0.40%
  • 6.75

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.73%
  • 4.19%
  • 31.62%
  • FII
  • DII
  • Others
  • 0.63%
  • 0.23%
  • 9.60%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.88
  • 12.68
  • 10.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.98
  • 10.84
  • 3.40

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.46
  • 8.74
  • 4.42

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.24
  • 35.94
  • 38.50

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.74
  • 7.17
  • 7.53

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.25
  • 21.84
  • 22.31

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
53.41
44.20
20.84%
39.85
44.76
-10.97%
43.62
49.75
-12.32%
50.69
45.73
10.85%
Expenses
37.61
33.14
13.49%
27.95
27.19
2.80%
36.43
32.04
13.70%
29.99
25.52
17.52%
EBITDA
15.80
11.05
42.99%
11.90
17.57
-32.27%
7.19
17.71
-59.40%
20.70
20.21
2.42%
EBIDTM
29.59%
25.01%
29.86%
39.26%
16.48%
35.60%
40.83%
44.19%
Other Income
0.24
0.70
-65.71%
0.69
0.57
21.05%
4.79
5.75
-16.70%
0.30
0.27
11.11%
Interest
2.11
1.41
49.65%
1.53
1.90
-19.47%
2.54
2.10
20.95%
2.63
1.06
148.11%
Depreciation
3.24
3.23
0.31%
3.18
3.23
-1.55%
3.20
3.64
-12.09%
3.42
2.72
25.74%
PBT
10.69
7.11
50.35%
7.88
13.02
-39.48%
6.24
17.71
-64.77%
14.95
16.69
-10.43%
Tax
4.01
0.91
340.66%
2.83
4.94
-42.71%
1.48
3.64
-59.34%
3.00
4.26
-29.58%
PAT
6.68
6.21
7.57%
5.05
8.09
-37.58%
4.76
14.07
-66.17%
11.95
12.43
-3.86%
PATM
12.51%
14.04%
12.67%
18.07%
10.91%
28.29%
23.57%
27.19%
EPS
7.85
7.67
2.35%
6.72
9.86
-31.85%
3.22
15.47
-79.19%
13.54
15.05
-10.03%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
187.57
183.27
178.07
135.94
123.11
100.89
90.64
69.05
65.10
48.26
41.97
Net Sales Growth
1.70%
2.92%
30.99%
10.42%
22.02%
11.31%
31.27%
6.07%
34.89%
14.99%
 
Cost Of Goods Sold
27.44
19.71
28.47
23.31
28.45
19.75
25.32
11.39
15.42
7.75
6.37
Gross Profit
160.13
163.56
149.60
112.63
94.65
81.14
65.32
57.65
49.68
40.51
35.60
GP Margin
85.37%
89.25%
84.01%
82.85%
76.88%
80.42%
72.07%
83.49%
76.31%
83.94%
84.82%
Total Expenditure
131.98
127.41
110.03
88.68
82.09
67.50
65.90
44.60
43.21
29.66
23.95
Power & Fuel Cost
-
8.13
7.83
6.37
5.59
5.81
4.77
4.40
3.30
2.96
2.32
% Of Sales
-
4.44%
4.40%
4.69%
4.54%
5.76%
5.26%
6.37%
5.07%
6.13%
5.53%
Employee Cost
-
40.65
28.93
23.24
18.32
15.44
12.32
9.84
9.06
6.87
5.82
% Of Sales
-
22.18%
16.25%
17.10%
14.88%
15.30%
13.59%
14.25%
13.92%
14.24%
13.87%
Manufacturing Exp.
-
13.21
11.34
9.45
7.06
7.85
5.25
5.28
4.15
4.09
2.88
% Of Sales
-
7.21%
6.37%
6.95%
5.73%
7.78%
5.79%
7.65%
6.37%
8.47%
6.86%
General & Admin Exp.
-
21.63
13.72
13.81
11.47
10.23
8.90
7.23
6.09
4.76
3.93
% Of Sales
-
11.80%
7.70%
10.16%
9.32%
10.14%
9.82%
10.47%
9.35%
9.86%
9.36%
Selling & Distn. Exp.
-
18.99
16.77
9.11
8.15
6.77
7.14
4.87
4.34
2.68
2.34
% Of Sales
-
10.36%
9.42%
6.70%
6.62%
6.71%
7.88%
7.05%
6.67%
5.55%
5.58%
Miscellaneous Exp.
-
5.10
2.98
3.40
3.05
1.64
2.20
1.58
0.84
0.54
2.34
% Of Sales
-
2.78%
1.67%
2.50%
2.48%
1.63%
2.43%
2.29%
1.29%
1.12%
0.64%
EBITDA
55.59
55.86
68.04
47.26
41.02
33.39
24.74
24.45
21.89
18.60
18.02
EBITDA Margin
29.64%
30.48%
38.21%
34.77%
33.32%
33.10%
27.29%
35.41%
33.63%
38.54%
42.94%
Other Income
6.02
6.37
7.21
2.55
0.42
0.88
0.34
0.79
0.20
0.24
0.13
Interest
8.81
7.67
6.63
4.04
3.50
3.72
4.83
6.46
3.26
2.83
2.53
Depreciation
13.04
13.23
11.76
9.66
7.00
5.75
5.92
5.41
4.43
4.12
4.48
PBT
39.76
41.33
56.86
36.12
30.93
24.81
14.33
13.37
14.41
11.90
11.15
Tax
11.32
10.32
16.16
13.05
8.15
5.63
4.82
4.20
5.34
4.41
3.59
Tax Rate
28.47%
24.97%
28.42%
36.13%
26.35%
22.69%
28.39%
31.41%
37.06%
37.06%
32.20%
PAT
28.44
29.17
41.56
25.62
23.55
19.19
12.47
9.45
9.26
7.61
7.56
PAT before Minority Interest
26.66
31.00
40.69
23.07
22.79
19.18
12.17
9.16
9.07
7.49
7.56
Minority Interest
-1.78
-1.83
0.87
2.55
0.76
0.01
0.30
0.29
0.19
0.12
0.00
PAT Margin
15.16%
15.92%
23.34%
18.85%
19.13%
19.02%
13.76%
13.69%
14.22%
15.77%
18.01%
PAT Growth
-30.29%
-29.81%
62.22%
8.79%
22.72%
53.89%
31.96%
2.05%
21.68%
0.66%
 
Unadjusted EPS
33.46
34.32
48.89
30.14
27.71
22.58
14.67
11.12
10.89
8.95
8.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
201.07
177.46
140.63
121.95
101.71
84.92
75.01
67.30
59.76
47.90
Share Capital
8.51
8.51
8.51
8.51
8.51
8.51
8.51
8.51
5.67
5.19
Total Reserves
192.57
168.95
132.13
113.44
93.20
76.41
66.50
58.79
54.09
41.07
Non-Current Liabilities
96.64
69.64
44.41
48.32
41.28
37.66
20.46
16.31
6.15
6.06
Secured Loans
76.48
58.35
36.54
44.62
33.09
30.89
14.76
13.71
1.29
3.51
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.90
0.76
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
81.34
48.66
54.63
38.01
38.20
35.01
45.47
38.89
28.22
27.70
Trade Payables
18.61
8.75
7.90
7.47
5.84
4.63
4.52
5.71
4.06
3.34
Other Current Liabilities
30.17
17.15
20.26
11.04
9.30
6.35
7.41
8.84
4.21
4.71
Short Term Borrowings
32.54
22.50
25.41
18.32
21.04
20.08
29.74
16.08
12.73
14.79
Short Term Provisions
0.02
0.26
1.07
1.18
2.02
3.95
3.80
8.27
7.21
4.87
Total Liabilities
384.47
299.46
244.04
212.88
185.84
160.46
142.22
123.70
95.43
82.30
Net Block
142.54
144.82
110.22
102.62
64.63
59.60
53.82
37.73
39.39
39.17
Gross Block
226.32
215.94
170.22
152.95
108.25
97.57
86.69
65.25
62.49
58.14
Accumulated Depreciation
83.78
70.98
60.00
50.33
43.62
37.97
32.87
27.52
23.09
18.97
Non Current Assets
226.86
157.80
145.59
132.91
111.63
100.45
85.12
73.90
49.30
44.11
Capital Work in Progress
74.15
7.05
31.81
21.29
36.46
32.60
20.55
28.89
6.30
0.04
Non Current Investment
0.00
0.00
0.00
0.00
0.07
0.28
0.28
0.28
0.00
0.00
Long Term Loans & Adv.
6.30
4.34
3.48
8.52
10.47
7.97
10.47
7.00
3.60
4.89
Other Non Current Assets
3.87
1.58
0.08
0.47
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
157.62
141.66
98.45
79.97
74.20
60.00
57.10
49.80
46.12
38.19
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
63.97
50.79
39.76
33.41
33.62
29.11
35.59
31.10
27.56
22.68
Sundry Debtors
58.44
32.87
32.29
26.53
26.24
17.76
14.06
15.04
14.36
13.22
Cash & Bank
23.53
41.05
13.39
11.48
5.28
6.58
4.85
2.63
3.70
1.59
Other Current Assets
11.68
5.63
4.06
3.48
9.05
6.55
2.60
1.03
0.50
0.70
Short Term Loans & Adv.
8.62
11.32
8.95
5.06
2.49
6.55
2.60
1.03
0.50
0.70
Net Current Assets
76.28
92.99
43.82
41.95
36.00
25.00
11.63
10.91
17.90
10.49
Total Assets
384.48
299.46
244.04
212.88
185.83
160.45
142.22
123.70
95.42
82.30

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
38.29
46.71
38.02
34.80
18.85
19.76
9.39
11.54
14.16
5.15
PBT
41.33
56.86
36.12
30.93
24.81
18.20
13.37
14.41
11.90
11.15
Adjustment
19.71
17.92
13.63
10.86
9.38
7.34
11.91
7.67
6.75
6.86
Changes in Working Capital
-13.65
-12.26
-2.31
0.11
-9.37
-0.33
-6.02
-5.04
-3.76
-10.37
Cash after chg. in Working capital
47.39
62.52
47.44
41.90
24.82
25.21
19.25
17.04
14.89
7.64
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-10.94
-15.81
-9.41
-7.06
-5.97
-5.45
-9.86
-5.50
-0.73
-2.49
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
1.84
0.00
0.00
-0.04
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-74.47
-21.73
-25.83
-30.19
-13.30
-21.21
-14.59
-22.55
-10.23
-3.71
Net Fixed Assets
-5.37
-11.03
-20.52
-15.30
-6.87
-12.04
-10.39
-20.32
-7.74
Net Investments
-12.45
-13.74
-5.88
0.07
0.21
-5.25
-0.85
-0.28
0.00
Others
-56.65
3.04
0.57
-14.96
-6.64
-3.92
-3.35
-1.95
-2.49
Cash from Financing Activity
18.62
2.65
-11.08
1.83
-6.68
6.76
7.38
9.90
-1.84
-0.81
Net Cash Inflow / Outflow
-17.56
27.63
1.12
6.45
-1.14
5.31
2.19
-1.12
2.10
0.64
Opening Cash & Equivalents
40.65
12.33
11.18
4.73
6.12
0.82
2.29
3.41
1.32
0.96
Closing Cash & Equivalent
23.09
40.65
12.33
11.18
4.99
6.12
4.48
2.29
3.41
1.59

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
236.36
208.61
165.32
143.35
119.56
96.86
88.18
79.11
70.25
59.41
ROA
9.07%
14.97%
10.10%
11.43%
11.08%
8.06%
6.89%
8.28%
8.42%
9.19%
ROE
16.38%
25.59%
17.57%
20.38%
20.56%
15.46%
12.88%
14.28%
14.12%
16.35%
ROCE
16.63%
26.64%
20.20%
19.75%
18.98%
16.53%
17.78%
20.10%
20.27%
19.76%
Fixed Asset Turnover
0.83
0.92
0.84
0.96
1.00
1.01
0.93
1.04
0.81
0.72
Receivable days
90.92
66.77
78.70
76.80
77.96
63.83
75.19
80.59
103.02
114.79
Inventory Days
114.27
92.80
97.89
97.55
111.14
127.14
172.29
160.79
187.67
196.97
Payable days
42.44
27.25
33.70
33.48
29.56
28.17
45.39
41.89
45.17
53.81
Cash Conversion Cycle
162.75
132.33
142.89
140.87
159.54
162.80
202.09
199.49
245.52
257.95
Total Debt/Equity
0.60
0.51
0.49
0.54
0.58
0.71
0.64
0.48
0.27
0.46
Interest Cover
6.39
9.57
9.95
9.84
7.67
4.52
3.07
5.41
5.21
5.41

News Update


  • Hester Biosciences' Nepal JV launches Live Thermo-tolerant PPR Vaccine
    23rd Nov 2020, 14:03 PM

    The vaccine will be available in packs of 25, 50 and 100 doses

    Read More
  • Hester Biosciences - Quarterly Results
    31st Oct 2020, 11:18 AM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.